[Medical management of reflux esophagitis].
When the cause of oesophagitis has been discovered, patients for whom surgical management is impossible may be successfully treated by improving oesophageal peristalsis, increasing the tone of the LES, and speeding up the emptying of the stomach. The best results are obtained in peptic oesophagitis, since the latest secretion-inhibiting drugs ensure constant reduction of the acidity of the gastric juice, as has been demonstrated by continuous pH monitoring.
D000464:Alginates / Q000627:therapeutic use; D000863:Antacids / Q000627:therapeutic use; D002229:Carbenoxolone / Q000627:therapeutic use; D002927:Cimetidine / Q000627:therapeutic use; D004942:Esophagitis, Peptic / Q000188:drug therapy*; D004943:Esophagogastric Junction / Q000187:drug effects; D005260:Female; D005746:Gastric Emptying / Q000187:drug effects; D006801:Humans; D008297:Male; D008787:Metoclopramide / Q000627:therapeutic use; D010528:Peristalsis / Q000187:drug effects
D000464:Alginates; D000863:Antacids; D002927:Cimetidine; D008787:Metoclopramide; D002229:Carbenoxolone
La terapia medica delle esofagiti da reflusso.